Messenger RNA (mRNA) vaccines may be the hottest thing in vaccine research. But even before the recent pandemic began, Memorial Sloan Kettering Cancer Center (MSK) researchers had already been testing mRNA vaccine technology with a different purpose — as a treatment for cancer.
Pancreatic cancer surgeon Vinod Balachandran, MD, has been leading the first clinical trial to test mRNA vaccines as a potential therapy for pancreatic cancer.
The vaccines are custom-made for every person.
Read More
